Literature DB >> 29297509

Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.

Deepak L Bhatt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29297509     DOI: 10.1038/nrcardio.2017.212

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Leaflet Thrombosis in Surgically Explanted or Post-Mortem TAVR Valves.

Authors:  Fernanda M Mangione; Tannas Jatene; Alexandra Gonçalves; Gregory A Fishbein; Richard N Mitchell; Marc P Pelletier; Tsuyoshi Kaneko; Pinak B Shah; Charles B Nyman; Douglas Shook; Ron Blankstein; Robert F Padera; Deepak L Bhatt
Journal:  JACC Cardiovasc Imaging       Date:  2017-01

2.  Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Authors:  Stuart J Connolly; John W Eikelboom; Jackie Bosch; Gilles Dagenais; Leanne Dyal; Fernando Lanas; Kaj Metsarinne; Martin O'Donnell; Anthony L Dans; Jong-Won Ha; Alexandr N Parkhomenko; Alvaro A Avezum; Eva Lonn; Liu Lisheng; Christian Torp-Pedersen; Petr Widimsky; Aldo P Maggioni; Camilo Felix; Katalin Keltai; Masatsugu Hori; Khalid Yusoff; Tomasz J Guzik; Deepak L Bhatt; Kelley R H Branch; Nancy Cook Bruns; Scott D Berkowitz; Sonia S Anand; John D Varigos; Keith A A Fox; Salim Yusuf
Journal:  Lancet       Date:  2017-11-10       Impact factor: 79.321

Review 3.  Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Authors:  Jackie Bosch; John W Eikelboom; Stuart J Connolly; Nancy Cook Bruns; Vivian Lanius; Fei Yuan; Frank Misselwitz; Edmond Chen; Rafael Diaz; Marco Alings; Eva M Lonn; Petr Widimsky; Masatsugu Hori; Alvaro Avezum; Leopoldo S Piegas; Deepak L Bhatt; Kelley R H Branch; Jeffrey L Probstfield; Yan Liang; Lisheng Liu; Jun Zhu; Aldo P Maggioni; Patricio Lopez-Jaramillo; Martin O'Donnell; Keith A A Fox; Ajay Kakkar; Alexander N Parkhomenko; Georg Ertl; Stefan Störk; Katalin Keltai; Matyas Keltai; Lars Ryden; Gilles R Dagenais; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomasz J Guzik; Peter B Verhamme; Dragos Vinereanu; Jae-Hyung Kim; Jong-Won Ha; Andrew M Tonkin; John D Varigos; Basil S Lewis; Camilo Felix; Khalid Yusoff; Philippe Gabriel Steg; Victor Aboyans; Kaj P Metsarinne; Sonia S Anand; Robert G Hart; Andre Lamy; Paul Moayyedi; Darryl P Leong; Mukul Sharma; Salim Yusuf
Journal:  Can J Cardiol       Date:  2017-06-08       Impact factor: 5.223

4.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

5.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Authors:  John W Eikelboom; Stuart J Connolly; Jackie Bosch; Gilles R Dagenais; Robert G Hart; Olga Shestakovska; Rafael Diaz; Marco Alings; Eva M Lonn; Sonia S Anand; Petr Widimsky; Masatsugu Hori; Alvaro Avezum; Leopoldo S Piegas; Kelley R H Branch; Jeffrey Probstfield; Deepak L Bhatt; Jun Zhu; Yan Liang; Aldo P Maggioni; Patricio Lopez-Jaramillo; Martin O'Donnell; Ajay K Kakkar; Keith A A Fox; Alexander N Parkhomenko; Georg Ertl; Stefan Störk; Matyas Keltai; Lars Ryden; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek J Guzik; Peter B Verhamme; Dragos Vinereanu; Jae-Hyung Kim; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; P Gabriel Steg; Kaj P Metsarinne; Nancy Cook Bruns; Frank Misselwitz; Edmond Chen; Darryl Leong; Salim Yusuf
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

6.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

Authors:  Raj R Makkar; Gregory Fontana; Hasan Jilaihawi; Tarun Chakravarty; Klaus F Kofoed; Ole De Backer; Federico M Asch; Carlos E Ruiz; Niels T Olsen; Alfredo Trento; John Friedman; Daniel Berman; Wen Cheng; Mohammad Kashif; Vladimir Jelnin; Chad A Kliger; Hongfei Guo; Augusto D Pichard; Neil J Weissman; Samir Kapadia; Eric Manasse; Deepak L Bhatt; Martin B Leon; Lars Søndergaard
Journal:  N Engl J Med       Date:  2015-10-05       Impact factor: 91.245

7.  Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.

Authors:  Tarun Chakravarty; Lars Søndergaard; John Friedman; Ole De Backer; Daniel Berman; Klaus F Kofoed; Hasan Jilaihawi; Takahiro Shiota; Yigal Abramowitz; Troels H Jørgensen; Tanya Rami; Sharjeel Israr; Gregory Fontana; Martina de Knegt; Andreas Fuchs; Patrick Lyden; Alfredo Trento; Deepak L Bhatt; Martin B Leon; Raj R Makkar
Journal:  Lancet       Date:  2017-03-19       Impact factor: 79.321

8.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Authors:  Sonia S Anand; Jackie Bosch; John W Eikelboom; Stuart J Connolly; Rafael Diaz; Peter Widimsky; Victor Aboyans; Marco Alings; Ajay K Kakkar; Katalin Keltai; Aldo P Maggioni; Basil S Lewis; Stefan Störk; Jun Zhu; Patricio Lopez-Jaramillo; Martin O'Donnell; Patrick J Commerford; Dragos Vinereanu; Nana Pogosova; Lars Ryden; Keith A A Fox; Deepak L Bhatt; Frank Misselwitz; John D Varigos; Thomas Vanassche; Alvaro A Avezum; Edmond Chen; Kelley Branch; Darryl P Leong; Shrikant I Bangdiwala; Robert G Hart; Salim Yusuf
Journal:  Lancet       Date:  2017-11-10       Impact factor: 79.321

Review 9.  Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Authors:  Francesco Costa; David van Klaveren; Stefan James; Dik Heg; Lorenz Räber; Fausto Feres; Thomas Pilgrim; Myeong-Ki Hong; Hyo-Soo Kim; Antonio Colombo; Philippe Gabriel Steg; Thomas Zanchin; Tullio Palmerini; Lars Wallentin; Deepak L Bhatt; Gregg W Stone; Stephan Windecker; Ewout W Steyerberg; Marco Valgimigli
Journal:  Lancet       Date:  2017-03-11       Impact factor: 79.321

10.  Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

Authors:  Christopher P Cannon; Savion Gropper; Deepak L Bhatt; Stephen G Ellis; Takeshi Kimura; Gregory Y H Lip; Ph Gabriel Steg; Jurriën M Ten Berg; Jenny Manassie; Jörg Kreuzer; Jon Blatchford; Joseph M Massaro; Martina Brueckmann; Ernesto Ferreiros Ripoll; Jonas Oldgren; Stefan H Hohnloser
Journal:  Clin Cardiol       Date:  2016-08-26       Impact factor: 2.882

  10 in total
  1 in total

1.  Risk factors for bleeding after dental extractions in patients receiving antithrombotic drugs - A case control study.

Authors:  Jinxia Huang; Jie Liu; Haitao Shi; Jun Wu; Jiyuan Liu; Jian Pan
Journal:  J Dent Sci       Date:  2021-10-20       Impact factor: 3.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.